pyrroles has been researched along with Eosinophilic Esophagitis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pinion, S | 1 |
| Glover, S; Liu, X; Mendoza Alvarez, LB | 1 |
| Fujiwara, Y; Hosomi, S; Kamata, N; Kuzumoto, T; Nadatani, Y; Nagami, Y; Otani, K; Sawada, A; Taira, K; Tanaka, F; Tanigawa, T; Watanabe, T | 1 |
| Ishimura, N; Kinoshita, Y | 1 |
1 review(s) available for pyrroles and Eosinophilic Esophagitis
| Article | Year |
|---|---|
Eosinophilic esophagitis in Japan: Focus on response to acid suppressive therapy.
Topics: Adult; Chronic Disease; Eosinophilic Esophagitis; Female; Humans; Japan; Male; Middle Aged; Prevalence; Proton Pump Inhibitors; Pyrroles; Sulfonamides | 2018 |
3 other study(ies) available for pyrroles and Eosinophilic Esophagitis
| Article | Year |
|---|---|
ACG 2021.
Topics: Adenoma; Antibodies, Monoclonal, Humanized; Circulating Tumor DNA; Colonoscopy; Colorectal Neoplasms; Congresses as Topic; Decontamination; Drug Therapy, Combination; Duodenoscopy; Eosinophilic Esophagitis; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Pyrroles; Sulfonamides | 2022 |
Treatment-resistant eosinophilic oesophagitis successfully managed with tofacitinib.
Topics: Adult; Arthralgia; Diagnosis, Differential; Eosinophilic Esophagitis; Humans; Male; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Treatment Outcome | 2019 |
Vonoprazan shows efficacy similar to that of proton pump inhibitors with respect to symptomatic, endoscopic, and histological responses in patients with eosinophilic esophagitis.
Topics: Eosinophilic Esophagitis; Humans; Proton Pump Inhibitors; Pyrroles; Sulfonamides | 2021 |